Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathway-Reference-Cited by-同舟云学术

Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathway

Published:2018-02-22 Issue:4 Volume:3 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Palam Lakshmi Reddy,Mali Raghuveer Singh,Ramdas Baskar,Srivatsan Sridhar Nonavinkere,Visconte Valeria,Tiu Ramon V.,Vanhaesebroeck Bart,Roers Axel,Gerbaulet Alexander,Xu Mingjiang,Janga Sarath Chandra^ORCID,Takemoto Clifford M.,Paczesny Sophie^ORCID,Kapur Reuben

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/94679/files/pdf

Reference63 articles.

1. Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature

2. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.

3. Diagnostic criteria and classification of mastocytosis: a consensus proposal

4. Mastocytosis: Pathology, genetics, and current options for therapy

5. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot study;American Journal of Hematology;2024-04-06

2. The Neurobeachin‐like 2 protein (NBEAL2) controls the homeostatic level of the ribosomal protein RPS6 in mast cells;Immunology;2024-01-25

3. The Potential of Liquid Biopsy in Detection of Endometrial Cancer Biomarkers: A Pilot Study;International Journal of Molecular Sciences;2023-04-25

4. Targeted Therapy for MPNs: Going Beyond JAK Inhibitors;Current Hematologic Malignancy Reports;2023-01-27

5. Epigenetic Modification of Cytosines in Hematopoietic Differentiation and Malignant Transformation;International Journal of Molecular Sciences;2023-01-15